4774-6 |
HLA-B60(40) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B60(40) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4774-6 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B60(40) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47740-6 |
Purine nucleoside phosphorylase |
CCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/min/mg hb |
|
|
|
|
|
|
CHEM |
|
47740-6 |
|
|
|
|
Both |
|
|
|
0 |
PNP RBC-cCnt |
|
|
|
N |
|
Catalytic Content; Chemistry; Erythrocytes; PNP; PNPase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/min/mg{Hb} |
|
|
|
0 |
47741-4 |
Purine nucleoside phosphorylase |
EntCat |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes |
|
MIN |
DefinitionDescription |
|
|
nmol/min/10*6 cells |
|
|
|
|
|
|
CHEM |
|
47741-4 |
|
|
|
|
Both |
|
|
|
0 |
PNP WBC Qn |
|
|
|
N |
|
Chemistry; Entitic catalytic activity; Leukocytes; PNP; PNPase; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/min/10*6{cells} |
|
|
The property (CCnt) given at creation was not consistent with the submitter's units, nmol/min/10*6 cells, which indicates they report catalytic activity per a given number of cells. Changed property to EntCat (Entitic catalytic activity). |
0 |
47742-2 |
Serine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Serine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47742-2 |
|
|
|
|
Both |
|
|
|
0 |
Serine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Substance concentration; WB; Whole blood |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47743-0 |
Serine/Amino acids.total |
SFr |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in Hair |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47743-0 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr Hair |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Har; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47744-8 |
Serine/Amino acids.total |
SFr |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47744-8 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr CSF |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47745-5 |
Serine/Amino acids.total |
SFr |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47745-5 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr Amn |
|
|
|
N |
|
AA; Acd; Acid; AF; Amino acid; Amino acids.total; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47746-3 |
Serine/Amino acids.total |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47746-3 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr SerPl |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47747-1 |
Serine/Amino acids.total |
SFr |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in DBS |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47747-1 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr DBS |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Substance fraction; Tot; Totl; WB; Whole blood |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47748-9 |
Serine/Amino acids.total |
SFr |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Serine/Amino acids.total in Specimen |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47748-9 |
|
|
|
|
Both |
|
|
|
0 |
Serine SFr Spec |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Misc; Miscellaneous; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Spec; Substance Fraction; To be specified in another part of the message; Tot; Totl; Unspecified |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47749-7 |
Somatotropin^1.5H post dose glucagon |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucagon |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47749-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1.5h p Gc SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Gc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
4775-3 |
HLA-B60(40) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B60(40) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4775-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B60(40) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47750-5 |
Somatotropin^1.5H post dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47750-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1.5h p Glc PO SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5h p Glc PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47751-3 |
Somatotropin^1.5H post dose TRH |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47751-3 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1.5h p TRH SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p TRH; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47752-1 |
Somatotropin^1.5H post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47752-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1.5h p Arg SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Arg; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47753-9 |
Somatotropin^1.5H post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47753-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1.5h p Ins IV SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47754-7 |
Somatotropin^10M post dose TRH |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --10 minutes post dose TRH |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47754-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH 10M p TRH SerPl-aCnc |
|
|
|
N |
|
10M p TRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47755-4 |
Somatotropin^10th specimen post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47755-4 |
|
|
|
|
Observation |
|
|
|
0 |
GH sp10 p chal SerPl-aCnc |
|
|
|
N |
|
After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp10; sp10 p chal; Spec; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47756-2 |
Somatotropin^15M pre dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47756-2 |
|
|
|
|
Observation |
|
|
|
0 |
GH 15M pre arg SerPl-aCnc |
|
|
|
N |
|
15M pre arg; Arbitrary Concentration; Arg; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Pl; Plasma; Plsm; Point in time; pre Arg; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47757-0 |
Somatotropin^15M post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47757-0 |
|
|
|
|
Observation |
|
|
|
0 |
GH 15M p Arg SerPl-aCnc |
|
|
|
N |
|
15M p Arg; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47758-8 |
Somatotropin^15M post dose glucagon |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47758-8 |
|
|
|
|
Observation |
|
|
|
0 |
GH 15M p Gc SerPl-aCnc |
|
|
|
N |
|
15M p Gc; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47759-6 |
Somatotropin^15M post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47759-6 |
|
|
|
|
Observation |
|
|
|
0 |
GH 15M p Ins IV SerPl-aCnc |
|
|
|
N |
|
15M p Ins IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
4776-1 |
HLA-B61(40) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B61(40) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4776-1 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B61(40) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47760-4 |
Somatotropin^1H post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47760-4 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1h p Arg SerPl-aCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Arg; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47761-2 |
Somatotropin^1H post dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47761-2 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1h p Glc PO SerPl-aCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Glc; 1h p Glc PO; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |